tetradecanoylphorbol acetate has been researched along with ritonavir in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allred, KF; Sengoku, T; Wilson, ME | 1 |
1 other study(ies) available for tetradecanoylphorbol acetate and ritonavir
Article | Year |
---|---|
Estrogen prevents cholesteryl ester accumulation in macrophages induced by the HIV protease inhibitor ritonavir.
Topics: Animals; Atherosclerosis; Carcinogens; CD36 Antigens; Cell Differentiation; Cell Line; Cholesterol Esters; Dose-Response Relationship, Drug; Estradiol; Estrogens; Female; Gene Expression Regulation; HIV Infections; HIV Protease Inhibitors; Humans; Macrophages; Male; Mice; Monocytes; PPAR gamma; Progesterone; Ritonavir; Sex Factors; Tetradecanoylphorbol Acetate; Time Factors; Transcription, Genetic | 2008 |